Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
about
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.Current and future standards in treatment of myasthenia gravisToxicities of immunosuppressive treatment of autoimmune neurologic diseases.Practical considerations on the use of rituximab in autoimmune neurological disordersCharacterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.Rituximab in the treatment of peripheral neuropathy associated with monoclonal gammopathy.B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab.Treatment strategies for myasthenia gravis.The challenge of pain management in patients with myasthenia gravis.Immunosuppressive therapies in myasthenia gravis.Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis.Response of patients with refractory myasthenia gravis to rituximab: a retrospective study.Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.Rituximab treatment of myasthenia gravis: A systematic review.Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravisMechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis.A New Classification System for IgG4 Autoantibodies.Treatment of MuSK-Associated Myasthenia Gravis.Management challenges in muscle-specific tyrosine kinase myasthenia gravis.
P2860
Q33385389-B6AAF77F-9DE6-40D1-A100-20DCF36F69E4Q34014734-F8DF8FCD-ADA0-4BCD-A670-FA8C6CD9B6AEQ34257903-C85FE3E7-825D-4B59-8CBD-8426BE00AFA8Q34409447-0EE45126-B808-491D-8156-E2D1442B4602Q34503367-857C6A62-C9B2-4D4C-806C-53FED29EE32AQ36607310-BA42263A-C36A-4C53-B093-510DAB92969EQ36897408-FEB222BA-4135-48A2-8CE3-870497401FE6Q37252133-9C0E08D6-E871-4A1D-A0C0-CC578E7B740CQ37344993-7EEAC588-904F-4A03-B1F5-B409FF29741BQ37483922-4662C390-7454-4866-B6D2-BC505BF85CFEQ37577775-3084E155-B197-4F6C-B55A-8A866FABF597Q37694576-68545F01-3603-4DF8-BE42-9BB72F89F28EQ37921751-12921A64-AFEF-40EA-A86F-6D5B0B47987DQ37968620-BEC14B78-776A-44F3-B471-D6AF19BA8166Q38259495-37C73764-2013-499C-BDEC-FBE8F3685452Q38633453-3B79192C-E75F-4F87-B60B-C48973195159Q38832557-66806CEC-82B6-4AA9-BB74-A29D7812E9CEQ39121466-5899A4DA-3280-4E62-AC57-C704A22FB055Q42765650-FCBAB17F-895C-4D37-9205-DD96D987AF47Q48142572-1441865E-E746-46B2-8A80-3148DBA2F8F3Q50327901-D168D314-511E-4F34-B209-1A062B07B1DFQ54379059-E54856D1-9BE3-474B-9808-029DE21FED86Q54464610-726A5ED5-5912-42F6-AD59-2FE8D9639AC9
P2860
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
@ast
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
@en
type
label
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
@ast
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
@en
prefLabel
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
@ast
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
@en
P2093
P2860
P356
P1433
P1476
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
@en
P2093
Berit Hain
Karin Jordan
Marcus Deschauer
Stephan Zierz
P2860
P304
P356
10.1002/MUS.20479
P577
2006-04-01T00:00:00Z